149 related articles for article (PubMed ID: 37591012)
1. Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes.
Luna-Marco C; de Marañon AM; Hermo-Argibay A; Rodriguez-Hernandez Y; Hermenejildo J; Fernandez-Reyes M; Apostolova N; Vila J; Sola E; Morillas C; Rovira-Llopis S; Rocha M; Victor VM
Redox Biol; 2023 Oct; 66():102849. PubMed ID: 37591012
[TBL] [Abstract][Full Text] [Related]
2. Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients.
Rovira-Llopis S; Bañuls C; de Marañon AM; Diaz-Morales N; Jover A; Garzon S; Rocha M; Victor VM; Hernandez-Mijares A
Free Radic Biol Med; 2017 Jul; 108():155-162. PubMed ID: 28359952
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes.
Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; de Marañon AM; Abad-Jimenez Z; Bañuls C; Rovira-Llopis S; Herance JR; Rocha M; Victor VM
Sci Rep; 2018 Oct; 8(1):15862. PubMed ID: 30367115
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Alterations and Enhanced Human Leukocyte/Endothelial Cell Interactions in Type 1 Diabetes.
Iannantuoni F; M de Marañon A; Abad-Jiménez Z; Canet F; Díaz-Pozo P; López-Domènech S; Morillas C; Rocha M; Víctor VM
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32650465
[TBL] [Abstract][Full Text] [Related]
5. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients.
Escribano-Lopez I; Diaz-Morales N; Rovira-Llopis S; de Marañon AM; Orden S; Alvarez A; Bañuls C; Rocha M; Murphy MP; Hernandez-Mijares A; Victor VM
Redox Biol; 2016 Dec; 10():200-205. PubMed ID: 27810734
[TBL] [Abstract][Full Text] [Related]
6. Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US.
Eberly LA; Yang L; Essien UR; Eneanya ND; Julien HM; Luo J; Nathan AS; Khatana SAM; Dayoub EJ; Fanaroff AC; Giri J; Groeneveld PW; Adusumalli S
JAMA Health Forum; 2021 Dec; 2(12):e214182. PubMed ID: 35977298
[TBL] [Abstract][Full Text] [Related]
7. Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?
Diaz-Morales N; Rovira-Llopis S; Bañuls C; Lopez-Domenech S; Escribano-Lopez I; Veses S; Jover A; Rocha M; Hernandez-Mijares A; Victor VM
Antioxid Redox Signal; 2017 Dec; 27(17):1439-1445. PubMed ID: 28467723
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia.
Hernandez-Mijares A; Rocha M; Rovira-Llopis S; Bañuls C; Bellod L; de Pablo C; Alvarez A; Roldan-Torres I; Sola-Izquierdo E; Victor VM
Diabetes Care; 2013 Jun; 36(6):1695-702. PubMed ID: 23300290
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia.
Hernandez-Mijares A; Bañuls C; Rovira-Llopis S; Diaz-Morales N; Escribano-Lopez I; de Pablo C; Alvarez A; Veses S; Rocha M; Victor VM
Atherosclerosis; 2016 Apr; 247():40-7. PubMed ID: 26868507
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor action in the vasculature.
Almutairi M; Al Batran R; Ussher JR
Peptides; 2019 Jan; 111():26-32. PubMed ID: 30227157
[TBL] [Abstract][Full Text] [Related]
11. Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients.
Hopkins ND; Cuthbertson DJ; Kemp GJ; Pugh C; Green DJ; Cable NT; Jones H
Diabetes Obes Metab; 2013 Aug; 15(8):770-3. PubMed ID: 23451821
[TBL] [Abstract][Full Text] [Related]
12. Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report.
Zheng MY; Yang JH; Shan CY; Zhou HT; Xu YG; Wang Y; Ren HZ; Chang BC; Chen LM
Cardiovasc Diabetol; 2013 May; 12():73. PubMed ID: 23642288
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial redox impairment and enhanced autophagy in peripheral blood mononuclear cells from type 1 diabetic patients.
Canet F; Díaz-Pozo P; Luna-Marco C; Fernandez-Reyes M; Vezza T; Marti M; Salazar JD; Roldan I; Morillas C; Rovira-Llopis S; Rocha M; Víctor VM
Redox Biol; 2022 Dec; 58():102551. PubMed ID: 36455476
[TBL] [Abstract][Full Text] [Related]
14. Relationship between PMN-endothelium interactions, ROS production and Beclin-1 in type 2 diabetes.
De Marañon AM; Iannantuoni F; Abad-Jiménez Z; Canet F; Díaz-Pozo P; López-Domènech S; Jover A; Morillas C; Mariño G; Apostolova N; Rocha M; Victor VM
Redox Biol; 2020 Jul; 34():101563. PubMed ID: 32416353
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes.
Longo M; Di Meo I; Caruso P; Muscio MF; Scappaticcio L; Maio A; Maiorino MI; Bellastella G; Signoriello G; Knop FK; Rizzo MR; Esposito K
Diabetes Res Clin Pract; 2023 Jun; 200():110688. PubMed ID: 37116797
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 3 and interleukin 1β expression in CD34+ cells from patients with rheumatoid arthritis: association with inflammation and vascular involvement.
Lo Gullo A; Mandraffino G; Imbalzano E; Mamone F; Aragona CO; D'Ascola A; Loddo S; Cinquegrani A; Alibrandi A; Mormina E; Bagnato G; Lo Gullo R; Sardo MA; Saitta A
Clin Exp Rheumatol; 2014; 32(6):922-9. PubMed ID: 25436985
[TBL] [Abstract][Full Text] [Related]
17. Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase.
Victor VM; Rovira-Llopis S; Bañuls C; Diaz-Morales N; Martinez de Marañon A; Rios-Navarro C; Alvarez A; Gomez M; Rocha M; Hernández-Mijares A
PLoS One; 2016; 11(3):e0151960. PubMed ID: 27007571
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
19. Malnutrition impairs mitochondrial function and leukocyte activation.
Bañuls C; de Marañon AM; Veses S; Castro-Vega I; López-Domènech S; Salom-Vendrell C; Orden S; Álvarez Á; Rocha M; Víctor VM; Hernández-Mijares A
Nutr J; 2019 Dec; 18(1):89. PubMed ID: 31878925
[TBL] [Abstract][Full Text] [Related]
20. Are Mitochondrial Fusion and Fission Impaired in Leukocytes of Type 2 Diabetic Patients?
Diaz-Morales N; Rovira-Llopis S; Bañuls C; Escribano-Lopez I; de Marañon AM; Lopez-Domenech S; Orden S; Roldan-Torres I; Alvarez A; Veses S; Jover A; Rocha M; Hernandez-Mijares A; Victor VM
Antioxid Redox Signal; 2016 Jul; 25(2):108-15. PubMed ID: 27043041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
